“Seeing the unknown” is the tagline for SpectralMD, a company that has developed an artificial intelligence-augmented imaging system to determine if a wound is healing.
Wound assessment is currently done primarily by eye, relying on experience,
The Dallas-based company is using its DeepView technology to aid the treatment of hard-to-heal and chronic wounds.
“Seeing the unknown” is the tagline for SpectralMD, a company that has developed an artificial intelligence-augmented imaging system to determine if a wound is healing.
Wound assessment is currently done primarily by eye, relying on experience,